SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-018570
Filing Date
2019-05-10
Accepted
2019-05-10 16:31:48
Documents
4
Effectiveness Date
2019-05-10

Document Format Files

Seq Description Document Type Size
1 S-8 clsd-s8.htm S-8 112332
2 EX-5.1 clsd-ex51_6.htm EX-5.1 10129
3 EX-23.1 clsd-ex231_73.htm EX-23.1 2507
4 GRAPHIC gnzsxdmiqhev000001.jpg GRAPHIC 2548
  Complete submission text file 0001564590-19-018570.txt   129659
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231383 | Film No.: 19815443
SIC: 2834 Pharmaceutical Preparations